|
Originally published In Press as doi:10.1074/jbc.M000894200 on April 11, 2000
J. Biol. Chem., Vol. 275, Issue 27, 20268-20273, July 7, 2000
ATP Crossing the Cell Plasma Membrane Generates an Ionic Current
in Xenopus Oocytes*
Elena
Bodas §,
Jordi
Aleu ,
Gemma
Pujol,
Mireia
Martín-Satué,
Jordi
Marsal, and
Carles
Solsona¶
From the Laboratory of Molecular and Cellular Neurobiology,
Department of Cell Biology and Pathology, Medical School, Hospital of
Bellvitge, University of Barcelona, Campus of Bellvitge, Feixa Llarga
s/n, L'Hospitalet de Llobregat, E-08907 Barcelona, Spain
Received for publication, February 3, 2000, and in revised form, March 24, 2000
 |
ABSTRACT |
The presence of ATP within cells is well
established. However, ATP also operates as an intercellular signal via
specific purinoceptors. Furthermore, nonsecretory cells can release ATP
under certain experimental conditions. To measure ATP release and
membrane currents from a single cell simultaneously, we used
Xenopus oocytes. We simultaneously recorded membrane
currents and luminescence. Here, we show that ATP release can be
triggered in Xenopus oocytes by hyperpolarizing pulses. ATP
release (3.2 ± 0.3 pmol/oocyte) generated a slow inward current
(2.3 ± 0.1 µA). During hyperpolarizing pulses, the permeability
for ATP4- was more than 4000 times higher than that for
Cl-. The sensitivity to GdCl3 (0.2 mM) of hyperpolarization-induced ionic current, ATP release
and E-ATPase activity suggests their dependence on stretch-activated
ion channels. The pharmacological profile of the current inhibition
coincides with the inhibition of ecto-ATPase activity. This enzyme is
highly conserved among species, and in humans, it has been cloned and
characterized as CD39. The translation, in Xenopus oocytes,
of human CD39 mRNA encoding enhances the ATP-supported current,
indicating that CD39 is directly or indirectly responsible for the
electrodiffusion of ATP.
 |
INTRODUCTION |
Eukaryotic cells constantly form ATP, which has a large variety of
functions. In addition, exocytosis of a variety of granules or vesicles
results in ATP release, such as in the neuromuscular junction (1), in
rat cerebral cortex synaptosomes (2), in celiac neurons (3), in
isolated cholinergic nerve terminals from Torpedo electric
organ (4), and chromaffin cells (5). Nonsecretory cells can also
release ATP, as in skeletal muscle (6), heart cells (7), erythrocytes
(8), Torpedo electric organ (9), astrocytes (10), smooth
muscle (11), and airway epithelium (12). Because cells of this type
contain few secretory granules or secretory vesicle-like structures, it
has also been suggested that ATP may not be released through a membrane
fusion pathway.
Indirect evidence has been obtained in support of the hypothesis of
nonsecretory exocytotic release of ATP. In patch clamp experiments
(13-15), it was found that cell membranes containing cystic fibrosis
transmembrane regulator
(CFTR)1 or related proteins
may be permeable to ATP. Direct measurement of ATP release by myosin
functionalized tips of atomic force microscope reveals hot spots of ATP
release on the surface of epithelial cells expressing CFTR (16). Other
experimental reports (12, 17-20) do not support this view, suggesting
that the diameter of the pore of CFTR is too small to allow ATP to
cross the plasma membrane. However, in this type of experiment, it is
impossible to measure ATP release and ionic currents simultaneously in
an individual cell, and so it was impossible to establish a direct relationship between the current activation and the release of ATP.
We have developed a simple method to detect ATP release in oocytes
subjected to a two-electrode voltage-clamp (Fig. 1A). We monitored, on line and simultaneously, the release of ATP and the
currents flowing across the plasma membrane in a single cell.
 |
EXPERIMENTAL PROCEDURES |
Simultaneous Voltage-Clamp Recording and ATP
Release--
Procedures for preparation of Xenopus laevis
oocytes and voltage-clamp recording were as described (21). ATP
detection was performed at least 48 h after defolliculation.
Oocytes were placed in a dark chamber at 20 °C and bathed in a
recording solution containing 115 mM NaCl, 2 mM
KCl, 1.8 mM CaCl2, and 5 mM
HEPES/NaOH, pH 7.4. A vial of firefly lantern luciferase extract from
Photinus pyralis (Sigma) was diluted in 2 ml of the
recording solution containing 5 mg/ml D-luciferin (Sigma).
The resulting suspension was centrifuged for 30 s in a benchtop
centrifuge. The supernatant was desalted in a 10-ml 10DG Bio-Rad column
equilibrated with recording solution containing 1.8 mM
MgCl2. The eluate was maintained at 4 °C and placed in
the 250-µl recording chamber. A plastic optic fiber of 1 mm diameter
was placed above the upper surface of an oocyte bathed in a
luciferin-luciferase enriched solution, between the two recording
electrodes, and the other end of the fiber was placed in front of a
photomultiplier (Hamamatsu, R374). The resulting electric signal was
filtered at 5 Hz in a Bessel filter (Frequency Devices) and collected
by the Digidata-1200A converter (Axon Instruments). In some cases, a
known dose of ATP was added through a third pipette, with a calibrated
volume ejected by pressure (PLI-100, Medical Systems). In some
experiments, six optic fibers were placed in front of the six planes of
the recording cuvette.
Characterization of Ionic Currents--
In some experiments,
Xenopus oocyte plasma membrane capacitance was measured
before and after applying a hyperpolarizing pulse from -60 to -180
mV. Cell membrane electrical capacitance was calculated by recording
the capacitative transient associated with a small voltage step (from
-60 to -90 mV), during which the inward current was not activated.
Integration of the transient yielded the charge (Q)
transferred during the voltage step (V), from which
capacitance (C) was calculated as follows: C = Q/V.
The reversal potential was calculated while the current was still
flowing. 100-ms pulses ranging from -220 to -150 mV, in 10-mV jumps,
were imposed in the last 2 s of 20-s hyperpolarizing pulses. The
currents were plotted against voltage, and extrapolation to zero was
calculated. The reversal potential of the residual current, calculated
at different potentials at the end of the 10-s hyperpolarizing pulse,
was -22 ± 3 mV (n = 10), ranging from -15 to
-23 mV.
Permeability of the membrane to ATP4- was calculated
according to the Goldman-Hodgkin-Katz equation, as follows,
|
(Eq. 1)
|
where F is Faraday's constant, R is the
gas constant, T is the absolute temperature in Kelvin,
Z is the valence of ATP or chloride, and E is the reversal
potential. Internal Cl concentration was 62 mM, according to Dascal (50).
The number of ATP molecules (n) that crossed the oocyte
plasma membrane was calculated as follows: n = I(dt)/(e-·|Z|), where I(dt) is the electrical charge (in coulombs) that crossed
the plasma membrane, thus generating the elicited current
(I), e- is the electrical charge of one electron
(in coulombs) and |Z| is the valence. The leak current
was subtracted, and the charge was calculated as the area delimited by
the current.
ATP Content of Xenopus Oocytes--
ATP content was measured in
groups of 10 oocytes, which were homogenized in the presence of
trichloroacetic acid 5%, left to stand for 30 min at 4 °C and
finally centrifuged in a benchtop centrifuge for 5 min. Trichloroacetic
acid from the supernatant was removed by washing the suspension in
ethyl-ether until the pH of the aqueous phase was above 4.5. The amount
of ATP was determined by the luciferin-luciferase luminescent reaction.
Ecto-ATPase Activity--
Ecto-ATPase (E-type ATPase) activity
of defolliculated Xenopus oocytes was assayed according to
(22), in groups of 10 oocytes incubated in a saline solution containing
ATP (1 mM). To activate ATPase, CaCl2 (1 mM) was added.
Expression of Human CD39 in Xenopus Oocytes--
Total RNA was
isolated from human B-lymphocytes using the UltraspecTM RNA
isolation system (Biotecx). A sample of 2.7 µg of total RNA served as
template for cDNA synthesis by reverse transcriptase (MuLV,
Perkin-Elmer). The sense primer
(5'-TCCCCCGGGCTTATGGAAGATACAAAGGAGTCTAAC-3') contained a sequence
identical to nucleotides 65-91 of human CD39. The antisense primer
(5'-TCCCCCGGGCTATACCATATCTTTCCAGAAATATGA-3') was complementary to
nucleotides 1574-1600 of the CD39 coding sequence. After
amplification, the PCR product (1530 bp) was subcloned into pCR2.1
plasmid (Invitrogen) and sequenced with the DNA sequencing kit (PE Bio
systems). This construct (10 µg) was linearized with BamHI (Promega),
and the resultant product was used for in vitro mRNA
synthesis using the mCAPTM RNA capping kit (Stratagene).
The mRNA obtained was injected (1-2 µg/µl) into oocytes 3 days
before starting current recording.
 |
RESULTS AND DISCUSSION |
In defolliculated Xenopus oocytes, hyperpolarizing
square pulses (Fig. 1B)
generated a slow inward current of varying amplitude (2.3 ± 0.1 µA; = 1.8 ± 0.6 s; n = 191),
depending on the oocyte batch. ATP release during the generation of
this current, measured in 40 oocytes, was 3.2 ± 0.3 pmol of
ATP/oocyte, in pulses from -60 to -200 mV. The amount of ATP released
was proportional to the amplitude of the hyperpolarizing pulse. The
pulses from -60 to -180 mV gave a significantly (p < 0.001) lower ATP peak (54 ± 9%; n = 10) and a
significantly (p < 0.001) lower inward current (54 ± 8%; n = 12) than pulses from -60 to -200
mV. There were no significant differences between these values.
Sometimes, for a few minutes after the end of the hyperpolarizing
pulse, a small residual current continued.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Voltage-dependent release of ATP
from defolliculated Xenopus oocytes.
A, for simultaneous recording of ATP release and plasma
membrane currents, we connected an optic fiber to a conventional
two-electrode voltage-clamp set up for Xenopus oocytes. In a
dark chamber, the oocyte was placed in a recording cuvette containing a
luciferin-luciferase mixture. ATP released from the oocytes excited
light emission by the chemiluminescent enzymes. Emitted photons were
captured by the optic fiber, which was connected to a photomultiplier.
o.f., optic fiber; me1 and me2,
microelectrodes 1 and 2; E, voltage-clamp amplifier;
Vm, resting membrane potential of oocyte;
phmtpl, photomultiplier. B, B.1, hyperpolarizing
pulses of 10 s, from -60 to -200 mV, in -20-mV steps, were
applied to an oocyte; holding potential, -60 mV. B.2,
currents elicited by the hyperpolarizing pulses were clearly recorded
after applying voltages below -160 mV. When membrane potential
returned to -60 mV, the currents disappeared very slowly. Currents
presented in the figure were not corrected for leak. B.3, in
voltages at which an inward current was generated, ATP release was
clearly revealed by the emission of light from the mixture of
luciferin-luciferase. Light was measured in arbitrary units
(a.u.).
|
|
We ruled out the exocytotic origin of ATP release from cortical
granules (23) of oocytes because it was independent of the external
calcium concentration (2.4 ± 0.2 pmol of ATP in the presence of
1.8 mM CaCl2 and 2.6 ± 0.3 pmol in
solutions to which CaCl2 was not added; n = 4). Cortical granules fuse with the plasma membrane during
fertilization, the oocyte membrane becomes depolarized and calcium
enters through voltage-sensitive channels. The hyperpolarizing pulses
did not open the voltage-dependent calcium channels at the
range used in these experiments. Furthermore, the membrane capacitance
of the oocytes (24) did not change significantly (203 ± 8 nanofarads before and 194 ± 7 nanofarads after applying the
hyperpolarizing pulse; n = 8). However, the increase in
capacitance due to the fusion of granules may have been below the
sensitivity of the recording techniques (between 10-15 nanofarads). If
we assume that ATP release is supported by the exocytosis of small granules with a diameter of 100 nm containing 100-200 mM
ATP, such as synaptic vesicles, which are also present in the oocyte, it would induce an increase of 50-90 nanofarads, which would release 2-3 pmol of ATP. Such an increase would be detectable by the recording methods used. We conclude, therefore, that ATP release is not directly
related to the exocytosis of secretory granules from the oocyte
cytoplasm. However, we cannot rule out the possibility that a few
membranous structures, such as secretory granules or caveolae, may be
incorporated into the oocyte plasmalemma. These structures could
contain a high density of a membrane protein that transport ATP out of
the cell. This mechanism of incorporation of ion channels to the cell
plasma membrane has been suggested for CFTR (25).
We also examined the ionic permeability associated with the slow inward
current previously described in Xenopus (26, 27) and in
Rana perezi (28) oocytes. Both groups concluded that the
current was not generated by microruptures of the plasma membrane, which should cause an entry of Na+. The inward current was
still present when external NaCl was replaced by
N-methyl-D-glucamine-Cl (26). We replaced 83%
of external NaCl (15 mM) with urea (200 mM),
and the current did not change significantly (-903 ± 33 nA in
oocytes bathed in urea-containing medium, -833 ± 23 nA in
oocytes bathed in physiological solution; n = 4). We
ruled out the participation of K+ in this current,
considering that substitution of Na+ by K+ in
the recording solution did not change the amplitude of the current
(-1767 ± 80 nA in oocytes recorded in Na+
substituted medium; -1835 ± 53 nA in oocytes bathed in
physiological solution; n = 5). In addition,
tetraethylammonium (10 mM) did not change the amplitude of
the current (1.5 ± 0.1 µA in 10 mM tetraethylammonium-treated oocytes, 1.5 ± 0.6 µA in
physiological solution; n = 8), nor was this current
sustained by Cl ; the substitution of Cl by
other anions did not change the amplitude of the inward current, (2.1 ± 0.3 µA (n = 5) for sodium gluconate;
2.3 ± 0.3 µA (n = 5) for sodium thiocyanate;
1.9 ± 0.5 µA for SO42-). The
blocking drug of voltage-dependent chloride channels
(anthracene-9-carboxylic acid) did not change the amplitude of the
inward current (1.8 ± 0.1 µA in both anthracene-9-carboxylic
acid-treated oocytes and oocytes bathed with physiological solution;
n = 4).
Alternatively, it has been suggested that ATP can cross the plasma
membrane through a hydrophobic channel, although the results are
controversial (12-15, 17-20). The reversal potential varied considerably from one oocyte batch to another, ranging from 17 to 124 mV, with a mean of 101 ± 19 mV (n = 10).
According to the Nernst equation, this reversal potential is in the
range of the equilibrium potential for ATP4-. Ionic ATP
crossing the plasma membrane may have generated this current. This was
supported by the finding that, using the Goldman-Hodgkin and Katz
equation, the calculated permeability of ATP4- was 4531 times higher than that of Cl (in the residual current
ATP4- is 4.5 times more permeable than Cl ).
In addition, the number of ATP molecules detected by the
luciferin-luciferase reaction was of the same order of magnitude as the
number calculated (see under "Experimental Procedures") from the
current (Fig. 2).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Release of ATP from defolliculated
Xenopus oocytes. A, to estimate the
amount of ATP released during a hyperpolarizing pulse, we added a known
dose of ATP near to the oocyte bathed in the luminescent mixture.
A1, voltage command; A2, current trace;
A3, light emitted by ATP release. A known quantity of an ATP
solution was ejected to estimate the amount of ATP released by a single
oocyte. B, comparison of the number of ATP molecules
detected by the chemiluminescent reaction of luciferin-luciferase and
the calculated number of molecules of ATP with four negative charges
that can cross the plasma membrane and thus produce the current
elicited by hyperpolarizing pulses. The number of chemiluminescently
detected molecules fits with the calculated number of molecules of
ATP4- flowing through the plasma membrane. This figure
also illustrates the variability of ATP release and currents in
different oocytes. C, relationship between the number of
molecules of ATP detected by the luciferin-luciferase reaction and the
calculated number of ATP4- molecules crossing the plasma
membrane. Black squares and continuous straight
line correspond to oocytes hyperpolarized from -60 to -200 mV.
White circles and discontinuous straight line
correspond to oocytes hyperpolarized from -60 to -180 mV.
|
|
The dependence of intracellular and extracellular ATP concentrations on
ATP flux was also assayed. Xenopus oocytes contained 180 ± 30 pmol ATP per oocyte; n = 7. However, we
were unable to determine what proportion of this ATP was present in the
free form in the cytosol, ready to be released or entrapped into
granules or vesicles, and what proportion was bound to proteins.
Divalent cations (Ca2+ and Mg2+) and pH
determine the ionic derivatives that can be formed from the ATP
molecule. The intracellular calcium concentration of Xenopus oocytes has been estimated to be 35 nM (29); in this range
of Ca2+ concentration and at pH 7.4, the ATP inside the
cell must be in the form of ATP4-. The extracellular level
of ATP per oocyte was 404 ± 55 fmol/ml (n = 3).
Nevertheless, the intracellular and extracellular concentrations of ATP
fluctuate because of the activation of intracellular ATPases and
extracellular ATP degradation by ectonucleotidases.
Decreasing the ATP content with cyanide treatment induced both the
inhibition of ATP release and a decrease in the charge carried by the
inward current elicited by hyperpolarizing pulses (Fig.
3). When ATP (10 mM) was
added to the extracellular solution, the inward current increased when
negative potentials were applied (Fig. 4,
A and B). This effect might be related to an
endogenous type P2x purinoceptor, but Xenopus
oocytes are completely devoid of P2x purinoceptors 48 h after defolliculation (30). In our experimental conditions with
48-72 h defolliculated oocytes, clamped at -60 mV, ATP (10 mM) did not, as expected, evoke any current in the presence
of P2x purinoceptors (data not shown). The ectonucleotidase described in Xenopus oocytes (22) belongs to the group of
E-type ATPases (ecto-ATPase or ecto-apyrase). These are structurally related to the CD39 lymphocyte antigen, which has recently been cloned
(31). ATPases usually need Mg2+ as a cofactor, whereas
E-type ATPases can hydrolyze ATP or ADP using either Ca2+
or Mg2+ as cofactor. The amount of ATP released from an
oocyte under hyperpolarization pulses did not change when soluble
apyrase (from potato) was added to the recording medium (data not
shown). The hyperpolarization may have blocked the E-ATPase activity
and enhanced the light signal by preventing ATP degradation. Indeed, it
has been demonstrated that soluble luciferase does not pick up a
transient phase of ATP release from platelets (32), except when
luciferase was placed on the surface of activated platelets through a
chimeric antibody-containing luciferase.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of cyanide on ATP release from oocytes
induced by hyperpolarization. A, recording from an
oocyte. A1, hyperpolarizing voltage command; A2,
current (leak current was not subtracted); A3, light emitted
by ATP release. B, recording from the same oocyte treated
with 1 mM NaCN for 10 min. B1, voltage command;
B2, current; B3, light emitted by ATP release.
Note that a known dose of ATP was added before and after perfusing with
NaCN, which indicates that the decrease in light emission was due to a
reduction of ATP release rather than interference in the luminescent
reaction. C, plot of results from five oocytes. C1, effect of 1 mM NaCN on
the charge mobilized by the evoked current; C2, effect of 1 mM NaCN on the hyperpolarization-induced release of ATP;
C3, changes in oocyte ATP content. Bars represent
mean ± S.E. White bars correspond to nontreated
oocytes. CN indicates oocytes treated with 1 mM NaCN. ***, p < 0.001.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 4.
Current enhancement by extracellular ATP and
by expression of human CD39. A, effect of the
extracellular ATP (10 mM) on the hyperpolarizing-elicited
inward current. A1, hyperpolarizing voltage command;
A2, current (10 mM extracellular ATP increased
the hyperpolarization-elicited current). Leak current was not
subtracted. B, plot of currents elicited by 10-s voltage
pulses, in the absence (open circles) and presence
(filled circles) of 10 mM ATP. In
hyperpolarizing pulses, the presence of ATP in the recording medium
increased the voltage-dependent currents. Each data
point represents mean ± S.E. (n = 5). C,
inward current elicited by hyperpolarizing pulses in water-injected
oocytes (open bar) and in oocytes injected with mRNA for
human CD39 (CD39-labeled bar). Each bar
represents mean ± S.E. from 47 oocytes injected with water and 39 oocytes injected with mRNA of human CD39, from three different
Xenopus donors .**, p < 0.01.
|
|
To test the role of E-ATPase in the current, the enzymatic activity and
ATP release (Table I) we used a blocker
of potassium channels, blockers of chloride channels of
Xenopus oocytes and inhibitors of E-ATPase activity.
Unfortunately, no specific inhibitors of this enzymatic activity are
available. Suramin, an antimalarial agent with a Ki
in the micromolar range for E-ATPase activity (33), abolishes either
the slow inward current or the E-ATPase activity of Xenopus
oocytes. Table I summarizes the relationship between the generation of
the slow inward current and the E-ATPase activity. The degradation of
ATP by E-ATPase (34 ± 2 pmol of Pi
min 1 oocyte 1;
n = 13) was similar to that previously described (22).
The E-ATPase activity and the inward current were insensitive to
Cl and K+ channel blockers, but they were
both inhibited by suramin. Zn2+ and a high concentration of
Ca2+ also inhibited the E-ATPase activity and the induced
hyperpolarizing inward current. DIDS and SITS (1 mM), which
are commonly used as Cl blockers, also inhibited the
E-ATPase activity and the elicited current. The inhibition induced by
DIDS (1 mM) was reversible, whereas that induced by SITS
was irreversible. A lower concentration of DIDS (0.1 mM)
partially inhibited the luciferin-luciferase reaction, in a such a way
that it was possible to detect ATP release from stimulated oocytes.
DIDS (0.1 mM) inhibited the current, the E-ATPase activity,
and ATP release by the same order of magnitude (Table I). In addition,
the lack of action of glibenclamide indicates that the protein that
supports ATP release is not of the ABC type. In summary, the inhibition
of E-ATPase always correlated with the inhibition of the inward
current. However, it has recently been reported that Gd3+
(200 µM) inhibits ATP release from rat hepatoma cells
(34). In those experiments, ATP release was induced by hypotonic
solution, suggesting that it is sensitive to cell volume changes. It
has also been demonstrated that gadolinium blocks stretch-activated ion
channels (35). We show (Table I) that solutions containing Gd3+ (200 µM) inhibited the
hyperpolarization-induced current, E-ATPase, and ATP release. Again,
there is an association between current, E-ATPase activity and ATP
release. We suggest that ATP release from oocytes can be triggered by
the activation of stretch-sensitive ion channels, which in turn may be
directly associated to E-ATPases. Indeed, mechanically gated channels
are present in Xenopus oocytes (27).
View this table:
[in this window]
[in a new window]
|
Table I
Relationship between activation current, ecto-ATPase activity, and ATP
release
Currents were evoked by hyperpolarizing pulses from 60 to 200 mV,
before and after perfusing the oocyte with the test solutions. The
inhibition of these agents was reversible after 15 min of washing,
except in the case of SIDS, for which the inhibition was irreversible.
The E-ATPase activity was determined in groups of 10 defolliculated
oocytes. Most of the agents that inhibited E-type ATPase activity also
inhibited the luminescent reaction of luciferin-luciferase: a known
dose of ATP was applied to the bath, and no response was recorded. The
inward current was inhibited in oocytes treated with SIDS and
extensively washed. In these treated oocytes, we measured ATP release
without any interference of SIDS with chemiluminescent enzymes; in this
case, oocytes were not able to release ATP under hyperpolarising
conditions. i.r., this condition interferes with the reaction.
|
|
Translation of the mRNA of human CD39 enhanced the inward current
(Fig. 4C), thus demonstrating a direct relationship between E-type ATPase and the inward current. In 26 oocytes injected with a
truncated form (nucleotides 640-750), the current was not enhanced. Indeed, it has been suggested (36) that E-type ATPases such as CD39
might be able to form membrane channels. The antigen CD39, like
P2x receptors and inwardly rectifying potassium channels, is an integral membrane protein, with two transmembrane domains and a
large extracellular region that become active when tetramers are formed
(36). This protein may participate in two apparently contradictory
functions: the release of ATP and its degradation. However, two
different activity states have been suggested (37) for E-ATPases, both
of which can account for our results: the E-type molecule acts as an
ionic channel or a membrane transporter of ATP in response to
hydrolysis or binding of ATP. The E-type ATPases may, in resting
conditions, be involved in some kind of transport process, by consuming
extracellular ATP; the voltage or stretch stimulus would change the
protein conformation, inducing ATP transport out of the cell. In
physiological conditions, cells do not reach the low levels of voltage
fixed in our experiments. The physiological stimulus for ATP release
may be stretching.
Different cells, such as muscle fibers, neurons, or lining epithelial
cells secrete ATP (see the Introduction). ATP release from epithelial
cells may be relevant to genetic diseases. Cystic fibrosis is a genetic
disease caused by amino acid mutations in the sequence of the CFTR
protein. CFTR is a membrane protein that is permeant for chloride
anions (18, 38-41) and is located in the apical plasma membrane of the
airway epithelium and other epithelial cells. The reduction of the
chloride secretion in the respiratory pathways may explain the
pathophysiology of cystic fibrosis patients (42). It has been suggested
that in addition to its contribution to Cl cell
permeability, CFTR can also support ATP permeability (15, 43-46).
Airway epithelium releases ATP under mechanical stress (12) or under
hyposmotic stress (47) in which cystic fibrosis patients epithelia fail
to release ATP. Three cell mechanisms have been suggested to explain
this ATP release (25). The first possibility is that CFTR may support
ATP release directly, and it should therefore permeate either chloride
or ATP ions. The second possibility is that ATP can be released through
a different kind of protein or ionic channel, which should, in turn, be
activated by CFTR. The third possibility is that cells incorporate the
ATP-releasing protein by the exocytosis of granules of it in their
membrane; CFTR would then be implicated in the regulation of
exocytosis. Our results support the second possibility, according to
which CD39 would be directly involved in ATP release, whereas CFTR
would play a modulatory role. A recent report (48), measuring the release of ATP from single oocytes, pointed out that oocytes from some
specific female donors expressing CFTR released ATP under certain
restricted conditions, such as the presence of cAMP and changes in
extracellular chloride concentrations. CFTR is a regulator of
epithelial Na+ channels (49). It is therefore possible that
CFTR can regulate the protein configuration or the channel permeability
of E-type ATPases as well. As mentioned before, E-type ATPases share a
molecular configuration related to epithelial Na+ channels;
they have a large extracellular loop and only two transmembrane domains. Possibly, CFTR can interact with E-type ATPases triggering ATP
release when activated by cAMP. However, our results do not rule out
the third possibility mentioned above, in which granules containing a
high concentration of E-ATPase are incorporated abruptly by exocytosis
to the plasma membrane under the control of CFTR.
 |
ACKNOWLEDGEMENTS |
We thank Prof. J. Dempster for kindly
providing the Whole Cell program and Prof. C. Patton for the generous
gift of the Chelator program. We are also indebted to I. Gómez de
Aranda and S. Castro for their technical assistance and to Serveis
Cientifico Tècnics and Servei d'Assesorament Lingüistic of
the Universitat de Barcelona. We thank Prof. E. M. Silinsky
(Northwestern University) and Professor J. M. Fernandez (Mayo
Clinic) for their comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported by Dirección General de
Enseñanza Superior e Investigación Científica from
the Spanish Government, the Comissió Interdepertamental de
Recerca i Innovació Tecnològica from the local Government
of the Generalitat de Catalunya, and Fundació La Marató de
TV3 Spain.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
Recipient of a grant from Fundació August Pi i Sunyer.
¶
To whom correspondence should be addressed. Tel.:
34-93-402-4279 or 34-93-403-5809; Fax: 34-93-403-5810; E-mail:
solsona@bellvitge. bvg.ub.es.
Published, JBC Papers in Press, April 11, 2000, DOI 10.1074/jbc.M000894200
 |
ABBREVIATIONS |
The abbreviations used are:
CFTR, cystic
fibrosis transmembrane regulator;
DIDS
4, 4'-diisothiocyanatostilbene-2'-disulfonic acid;
SITS, 4-acetamido-4'isothiocyanatostilbene-2,2'-disulfonic acid;
E-type
ATPase, ecto-ATPase.
 |
REFERENCES |
| 1.
|
Silinsky, E. M.
(1975)
J. Physiol. Lond.
247,
145-162
|
| 2.
|
White, T. D.
(1977)
Nature
267,
67-68
|
| 3.
|
Silinsky, E. M.,
Gerzanich, V.,
and Vanner, S. M.
(1992)
Br. J. Pharmacol.
106,
762-763
|
| 4.
|
Meunier, F.,
Israel, M.,
and Lesbats, B.
(1975)
Nature
257,
407-408
|
| 5.
|
Rojas, E.,
Pollard, H. B.,
and Heldman, E.
(1985)
FEBS Lett.
185,
323-327
|
| 6.
|
Forrester, T.
(1966)
J. Physiol. Lond.
186,
107P-109P
|
| 7.
|
Forrester, T.,
and Williams, C. A.
(1977)
J. Physiol. Lond.
272,
44P-45P
|
| 8.
|
Bergfeld, G. R.,
and Forrester, T.
(1992)
Cardiovasc. Res.
26,
40-47
|
| 9.
|
Israel, M.,
Lesbats, B.,
Manaranche, R.,
Marsal, J.,
Mastour-Frachon, P.,
and Meunier, F. M.
(1977)
J. Neurochem.
28,
1259-1267
|
| 10.
|
Queiroz, G.,
Gebicke, H. P.,
Schobert, A.,
Starke, K.,
and von Kugelgen, I.
(1997)
Neuroscience
78,
1203-1208
|
| 11.
|
Pearson, J. D.,
and Gordon, J. L.
(1979)
Nature
281,
384-386
|
| 12.
|
Grygorczyk, R.,
and Hanrahan, J. W.
(1997)
Am. J. Physiol.
272,
C1058-C1066
|
| 13.
|
Abraham, E. H.,
Prat, A. G.,
Gerweck, L.,
Seneveratne, T.,
Arceci, R. J.,
Kramer, R.,
Guidotti, G.,
and Cantiello, H. F.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
312-316
|
| 14.
|
Bosch, I.,
Jackson, G. R., Jr,
Croop, J. M.,
and Cantiello, H. F.
(1996)
Am. J. Physiol.
271,
C1527-C1538
|
| 15.
|
Cantiello, H. F.
(1997)
Biosci. Rep.
17,
147-171
|
| 16.
|
Schneider, S. W.,
Egan, M. E.,
Jena, B. P.,
Guggino, W. B.,
Oberleithner, H.,
and Geibel, J. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
12180-12185
|
| 17.
|
Grygorczyk, R.,
Tabcharani, J. A.,
and Hanrahan, J. W.
(1996)
J. Membr. Biol.
151,
139-148
|
| 18.
|
Reddy, M. M.,
Quinton, P. M.,
Haws, C.,
Wine, J. J.,
Grygorczyk, R.,
Tabcharani, J. A.,
Hanrahan, J. W.,
Gunderson, K. L.,
and Kopito, R. R.
(1996)
Science
271,
1876-1879
|
| 19.
|
Sugita, M.,
Yue, Y.,
and Foskett, J. K.
(1998)
EMBO J.
17,
898-908
|
| 20.
|
Watt, W. C.,
Lazarowski, E. R.,
and Boucher, R. C.
(1998)
J. Biol. Chem.
273,
14053-14058
|
| 21.
|
Miledi, R.,
Parker, I.,
and Sumikawa, K.
(1982)
EMBO J.
1,
1307-1312
|
| 22.
|
Ziganshin, A. U.,
Ziganshina, L. E.,
King, B. E.,
and Burnstock, G.
(1995)
Pfluegers Arch.
429,
412-418
|
| 23.
|
Dumont, J. N.
(1972)
J. Morphol.
136,
153-179
|
| 24.
|
Kado, R. T.
(1993)
Methods Enzymol.
221,
273-299
|
| 25.
|
Devidas, S.,
and Guggino, W. B.
(1997)
Curr. Opin. Cell Biol.
9,
547-552
|
| 26.
|
Kowdley, G. C.,
Ackerman, S. J.,
John, J. E.,
Jones, L. R.,
and Moorman, J. R.
(1994)
J. Gen. Physiol.
103,
217-230
|
| 27.
|
Zhang, Y.,
and Hamill, O. P.
(2000)
J. Physiol.
523.1,
83-99
|
| 28.
|
Ivorra, I.,
and Morales, A.
(1997)
Pfluegers Arch.
434,
413-421
|
| 29.
|
Yao, Y.,
and Parker, I.
(1992)
J. Physiol. Lond.
458,
319-333
|
| 30.
|
Arellano, R. O.,
Garay, E.,
and Miledi, R.
(1998)
Am. J. Physiol.
274,
C333-C340
|
| 31.
|
Wang, T. F.,
and Guidotti, G.
(1996)
J. Biol. Chem.
271,
9898-9901
|
| 32.
|
Beigi, R.,
Kobatake, E.,
Aizawa, M.,
and Dubyak, G. R.
(1999)
Am. J. Physiol
276,
C267-C278
|
| 33.
|
Martí, E.,
Cantí, C.,
Gómez de Aranda, I.,
Miralles, F.,
and Solsona, C.
(1996)
Br. J. Pharmacol.
118,
1232-1236
|
| 34.
|
Roman, R. M.,
Feranchak, A. P.,
Davison, A. K.,
Schwiebert, E. M.,
and Fitz, J. G.
(1999)
Am J. Physiol
277,
G1222-G1230
|
| 35.
|
Franco, A., Jr.,
Winegar, B. D.,
and Lansman, J. B.
(1991)
Biophys. J.
59,
1164-1170
|
| 36.
|
Wang, T. F.,
Ou, Y.,
and Guidotti, G.
(1998)
J. Biol. Chem.
273,
24814-24821
|
| 37.
|
Beeler, T. J.,
Gable, K. S.,
and Keffer, J. M.
(1983)
Biochim. Biophys. Acta
734,
221-234
|
| 38.
|
Cantiello, H. F.,
Prat, A. G.,
Reisin, I. L.,
Ercole, L. B.,
Abraham, E. H.,
Amara, J. F.,
Gregory, R. J.,
and Ausiello, D. A.
(1994)
J. Biol. Chem.
269,
11224-11232
|
| 39.
|
Schultz, B. D.,
Venglarik, C. J.,
Bridges, R. J.,
and Frizzell, R. A.
(1995)
J. Gen. Physiol.
105,
329-361
|
| 40.
|
Ko, Y. H.,
Delannoy, M.,
and Pedersen, P. L.
(1997)
Biochemistry
36,
5053-5064
|
| 41.
|
Aleksandrov, A.,
and Riordan, J. R.
(1998)
FEBS Lett.
431,
97-101
|
| 42.
|
Ackerman, M. J.,
and Clapham, D. E.
(1997)
N. Engl. J. Med.
336,
1575-1586 (published erratum appears in N. Engl. J. Med. (1997) 337, 579).
|
| 43.
|
Reisin, I. L.,
Prat, A. G.,
Abraham, E. H.,
Amara, J. F.,
Gregory, R. J.,
Ausiello, D. A.,
and Cantiello, H. F.
(1994)
J. Biol. Chem.
269,
20584-20591
|
| 44.
|
Prat, A. G.,
Reisin, I. L.,
Ausiello, D. A.,
and Cantiello, H. F.
(1996)
Am. J. Physiol.
270,
C538-C545
|
| 45.
|
Abraham, E. H.,
Okunieff, P.,
Scala, S.,
Vos, P.,
Oosterveld, M. J.,
Chen, A. Y.,
and Shrivastav, B.
(1997)
Science
275,
1324-1326
|
| 46.
|
Pasyk, E.,
and Foskett, J. K.
(1997)
J. Biol. Chem.
272,
7746-7751
|
| 47.
|
Taylor, A. L.,
Kudlow, B. A.,
Marrs, K. L.,
Gruenert, D. C.,
Guggino, W. B.,
and Schwiebert, E. M.
(1998)
Am. J. Physiol. Cell Physiol.
44,
C1391-C1406
|
| 48.
|
Jiang, Q. S.,
Mak, D.,
Devidas, S.,
Schwiebert, E. M.,
Bragin, A.,
Zhang, Y. L.,
Skach, W. R.,
Guggino, W. B.,
Foskett, J. K.,
and Engelhardt, J. F.
(1998)
J. Cell Biol.
143,
645-657
|
| 49.
|
Grubb, B. R.,
Vick, R. N.,
and Boucher, R. C.
(1994)
Am. J. Physiol.
266,
C1478-C1483
|
| 50.
|
Dascal, N.
(1987)
CRC Crit. Rev. Biochem.
22,
317-387
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Gergs, P. Boknik, W. Schmitz, A. Simm, R.-E. Silber, and J. Neumann
A positive inotropic effect of ATP in the human cardiac atrium
Am J Physiol Heart Circ Physiol,
April 1, 2008;
294(4):
H1716 - H1723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nandigama, M. Padmasekar, M. Wartenberg, and H. Sauer
Feed Forward Cycle of Hypotonic Stress-induced ATP Release, Purinergic Receptor Activation, and Growth Stimulation of Prostate Cancer Cells
J. Biol. Chem.,
March 3, 2006;
281(9):
5686 - 5693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Boudreault and R. Grygorczyk
Cell swelling-induced ATP release is tightly dependent on intracellular calcium elevations
J. Physiol.,
December 1, 2004;
561(2):
499 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bao, F. Sachs, and G. Dahl
Connexins are mechanosensitive
Am J Physiol Cell Physiol,
November 1, 2004;
287(5):
C1389 - C1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ito, M. Son, S. Sato, T. Ishikawa, M. Kondo, S. Nakayama, K. Shimokata, and H. Kume
ATP Release Triggered by Activation of the Ca2+-Activated K+ Channel in Human Airway Calu-3 Cells
Am. J. Respir. Cell Mol. Biol.,
March 1, 2004;
30(3):
388 - 395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhong, R. Malhotra, and G. Guidotti
ATP Uptake in the Golgi and Extracellular Release Require Mcd4 Protein and the Vacuolar H+-ATPase
J. Biol. Chem.,
August 29, 2003;
278(35):
33436 - 33444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Aleu, M. Martin-Satue, P. Navarro, I. P. de Lara, L. Bahima, J. Marsal, and C. Solsona
Release of ATP induced by hypertonic solutions in Xenopus oocytes
J. Physiol.,
February 15, 2003;
547(1):
209 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sauer, R. Stanelle, J. Hescheler, and M. Wartenberg
The DC electrical-field-induced Ca2+ response and growth stimulation of multicellular tumor spheroids are mediated by ATP release and purinergic receptor stimulation
J. Cell Sci.,
August 15, 2002;
115(16):
3265 - 3273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K Dutta, Y. Okada, and R. Z Sabirov
Regulation of an ATP-conductive large-conductance anion channel and swelling-induced ATP release by arachidonic acid
J. Physiol.,
August 1, 2002;
542(3):
803 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. P. Hamill and B. Martinac
Molecular Basis of Mechanotransduction in Living Cells
Physiol Rev,
April 1, 2001;
81(2):
685 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Boudreault and R. Grygorczyk
Cell swelling-induced ATP release and gadolinium-sensitive channels
Am J Physiol Cell Physiol,
January 1, 2002;
282(1):
C219 - C226.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|